IGC Pharma Inc (IGC)
0.3541
0.00 (0.00%)
USD |
NYAM |
Sep 27, 16:00
0.42
+0.07
(+18.61%)
After-Hours: 20:00
IGC Pharma Gross Profit (TTM): 0.641M for June 30, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 0.641M |
March 31, 2024 | 0.733M |
December 31, 2023 | 0.625M |
September 30, 2023 | 0.594M |
June 30, 2023 | 0.555M |
March 31, 2023 | 0.442M |
December 31, 2022 | 0.447M |
September 30, 2022 | 0.407M |
June 30, 2022 | 0.31M |
March 31, 2022 | 0.194M |
December 31, 2021 | 0.153M |
September 30, 2021 | 0.105M |
June 30, 2021 | 0.093M |
March 31, 2021 | 0.113M |
December 31, 2020 | 0.102M |
September 30, 2020 | 0.118M |
June 30, 2020 | 0.12M |
March 31, 2020 | 0.115M |
December 31, 2019 | 0.126M |
September 30, 2019 | 0.141M |
June 30, 2019 | 0.131M |
March 31, 2019 | 0.132M |
December 31, 2018 | 0.029M |
September 30, 2018 | 0.023M |
June 30, 2018 | 0.077M |
Date | Value |
---|---|
March 31, 2018 | 0.081M |
December 31, 2017 | 0.1643M |
September 30, 2017 | 0.2533M |
June 30, 2017 | 0.2529M |
March 31, 2017 | 0.2935M |
December 31, 2016 | 0.5535M |
September 30, 2016 | 0.6316M |
June 30, 2016 | 0.7259M |
March 31, 2016 | 0.8433M |
December 31, 2015 | 0.6987M |
September 30, 2015 | 0.6918M |
June 30, 2015 | 0.7072M |
March 31, 2015 | 0.5797M |
December 31, 2014 | 0.4511M |
September 30, 2014 | 0.2617M |
June 30, 2014 | 0.2705M |
March 31, 2014 | 0.3816M |
December 31, 2013 | 0.6033M |
September 30, 2013 | 1.338M |
June 30, 2013 | 1.391M |
March 31, 2013 | 1.533M |
December 31, 2012 | 0.6424M |
September 30, 2012 | -0.1396M |
June 30, 2012 | -0.3741M |
March 31, 2012 | -0.6184M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
0.093M
Minimum
Jun 2021
0.733M
Maximum
Mar 2024
0.3067M
Average
0.1735M
Median
Gross Profit (TTM) Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.143M |
NovaBay Pharmaceuticals Inc | 7.039M |
Protalix BioTherapeutics Inc | 12.25M |
Palatin Technologies Inc | 5.700M |